Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Electroceuticals LLC currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This active matter is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. The prosecution profile shows a singular focus, with the company's current intellectual property efforts concentrated in a specific area of mechanical and medical innovation.
The busiest examiner for the portfolio is HULBERT, AMANDA K, who is overseeing the 1 pending office action. As HULBERT, AMANDA K handles the only pending action for the company, the prosecution strategy is entirely focused on addressing the specific concerns of this individual. The alignment of the busiest examiner's workload with the total pending actions suggests a streamlined administrative process.
The presence of 1 distinct art unit for the 1 pending office action confirms that the company is not currently facing multiple simultaneous examinations across different USPTO departments. Practitioners can focus their efforts on the specific standards of the Medical Devices & Mechanical Engineering sector. This centralized workload minimizes the complexity of the company's current patent prosecution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HULBERT, AMANDA K | 1 | 84.6% | +4.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18594416 | SYSTEMS, METHODS AND DEVICES FOR BIOELECTRONIC NEUROCODE-BASED MEDICAL TREATMENT | HULBERT, AMANDA K | 12d |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18594416 | SYSTEMS, METHODS AND DEVICES FOR BIOELECTRONIC NEUROCODE-BASED MEDICAL TREATMENT | HULBERT, AMANDA K | 3792 | DP | Final Rejection | 12d | Pending | Mar 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial